Actively Recruiting
A Study of MK-7240 in Healthy Participants (MK-7240-009)
Led by Merck Sharp & Dohme LLC · Updated on 2026-04-08
330
Participants Needed
2
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to learn what happens to MK-7240 in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of MK-7240 and if people tolerate it.
CONDITIONS
Official Title
A Study of MK-7240 in Healthy Participants (MK-7240-009)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 55 years
- Body mass index (BMI) between 18 and 32 kg/m²
You will not qualify if you...
- History of more than one episode of herpes zoster infection or disseminated herpes zoster infection
- History of or current active tuberculosis infection or untreated latent tuberculosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Nucleus Network ( Site 0002)
Brisbane, Queensland, Australia, 4006
Actively Recruiting
2
Nucleus Network ( Site 0001)
Melbourne, Victoria, Australia, 3004
Actively Recruiting
Research Team
T
Toll Free Number
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here